SPAR Group, Inc. Reports First Quarter 2025 Results
“Outside of our solid performance, there are two other items that merit comment. The first is the termination of the merger agreement with
“The second item is our delayed filings. Our 10-K filing was late because we expected to be private and the 10-Q that we are filing today is late because one follows the other. We will be current once this is filed with all filings and our shareholders should be enthusiastic about our performance.
“Lastly, we are now positioned to make some really exciting announcements over the next six months, and our second quarter performance looks good. I want to thank the employees of SPAR and our Board who have positioned the company for the next phase of success. Now that we have reset our footing, I am excited about our future,” said Matacunas.
First Quarter 2025 Highlights
- Net revenues were
$34.0 million . - Consolidated Gross Margin was 21.4% of sales, compared to 19.7% of sales in the prior year period.
- Net income attributable to
SPAR Group, Inc. from continuing operations was$0.5 million , or$0.02 per diluted share, compared to$6.6 million , or$0.26 per diluted share in the prior year quarter. The 2024 first quarter includes a$7.2 million non-cash gain on sale and other smaller non-recurring or non-cash items.
- Adjusted EBITDA attributable to
SPAR Group, Inc. was$1.5 million , or 4.4% of sales, compared to the prior quarter of$2.5 million , or 5.0% of sales.
Financial Position as of
The Company’s total worldwide liquidity at the end of the quarter was
About
Cautionary Note Regarding Forward-Looking Statements
This Press Release contains, and the above referenced recorded comments, will contain “forward-looking statements” within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, made by, or respecting, SPAR Group, Inc. (“SGRP”) and its subsidiaries (together with SGRP, “SPAR”, “SPAR Group” or the “Company”), filed in an Annual Report on Form 10-K/A by SGRP with the Securities and Exchange Commission (the “SEC”) for its fiscal year ended December 31, 2024, and SGRP’s Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports and statements as and when filed with the SEC (including the Quarterly Report, the Annual Report and the Proxy Statement, the Information Statement, the Second Special Meeting Proxy/Information Statement, each a “SEC Report”). “Forward-looking statements” are defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other applicable federal and state securities laws, rules and regulations, as amended (together with the Securities Act and Exchange Act, the “Securities Laws”).
The forward-looking statements made by the Company in this Press Release may include (without limitation) any expectations, guidance or other information respecting the pursuit or achievement of the Company’s corporate strategic objectives. The Company’s forward-looking statements also include, in particular and without limitation, those made in “Business”, “Risk Factors”, “Legal Proceedings”, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report. You can identify forward-looking statements in such information by the Company’s use of terms such as “may”, “will”, “expect”, “intend”, “believe”, “estimate”, “anticipate”, “continue”, “plan”, “project” or similar words or variations or negatives of those words.
You should carefully consider (and not place undue reliance on) the Company’s forward-looking statements, risk factors and the other risks, cautions and information made, contained or noted in or incorporated by reference into this Press Release, the Annual Report, the Proxy Statement and the other applicable SEC Reports that could cause the Company’s actual performance or condition (including its assets, business, clients, capital, cash flow, credit, expenses, financial condition, income, liabilities, liquidity, locations, marketing, operations, performance, prospects, sales, strategies, taxation or other achievement, results, risks, trends or condition) to differ materially from the performance or condition planned, intended, anticipated, estimated or otherwise expected by the Company (collectively, “expectations”) and described in the information in the Company’s forward-looking and other statements, whether expressed or implied. Although the Company believes them to be reasonable, those expectations involve known and unknown risks, uncertainties, and other unpredictable factors (many of which are beyond the Company’s control) that could cause those expectations to fail to occur or be realized or such actual performance or condition to be materially and adversely different from the Company’s expectations. In addition, new risks and uncertainties arise from time to time, and it is impossible for the Company to predict these matters or how they may arise or affect the Company. Accordingly, the Company cannot assure you that its expectations will be achieved in whole or in part, that the Company has identified all potential risks, or that the Company can successfully avoid or mitigate such risks in whole or in part, any of which could be significant and materially adverse to the Company and the value of your investment in SGRP’s Common Stock.
You should also carefully review the risk factors described in the Annual Report (See Item 1A – Risk Factors) and any other risks, cautions or information made, contained or noted in or incorporated by reference into the Annual Report, the Proxy Statement or other applicable SEC Report. All forward-looking and other statements or information attributable to the Company or persons acting on its behalf are expressly subject to and qualified by all such risk factors and other risks, cautions and information.
The Company does not intend or promise, and the Company expressly disclaims any obligation, to publicly update or revise any forward-looking statements, risk factors or other risks, cautions or information (in whole or in part), whether as a result of new information, risks or uncertainties, future events or recognition or otherwise, except as and to the extent required by applicable law.
| Media Contact: | Investor Relations Contact: | ||
| Three |
|||
| 908-272-3930 | 214-616-2207 | ||
| ron@rampr.com | smartin@threepa.com |
- Financial Statements Follow –
| SPAR Group, Inc. and Subsidiaries | ||||||
| Condensed Consolidated Statements of Operations | ||||||
| (unaudited) | ||||||
| (In thousands, except per share amounts) | ||||||
| Three Months Ended | ||||||
| 2025 | 2024 | |||||
| Net revenues | $ | 34,041 | $ | 49,396 | ||
| Field Management | 2,334 | 2,240 | ||||
| Direct Expenses | 24,432 | 37,444 | ||||
| Cost of Revenues | 26,766 | 39,684 | ||||
| Gross profit | 7,275 | 9,712 | ||||
| Selling, general and administrative expense | 5,872 | 7,723 | ||||
| (Gain) on sale of business | - | (7,157 | ) | |||
| Depreciation and amortization | 367 | 475 | ||||
| Operating income | 1,036 | 8,671 | ||||
| Interest expense | 469 | 475 | ||||
| Other expense (income), net | (9 | ) | 7 | |||
| Income before income tax expense | 576 | 8,189 | ||||
| Income tax expense | 114 | 1,393 | ||||
| Income from continuing operations | 462 | 6,796 | ||||
| Discontinued Operations | - | |||||
| Income from discontinued operations | - | 846 | ||||
| Income tax expense | - | (461 | ) | |||
| Net income from discontinued operations | - | 385 | ||||
| Net income | 462 | 7,181 | ||||
| Net income attributable to non-controlling interest | - | (554 | ) | |||
| Net income attributable to |
$ | 462 | $ | 6,627 | ||
| Basic earnings per common share attributable to |
$ | 0.02 | 0.26 | |||
| Diluted earnings per common share attributable to |
$ | 0.02 | $ | 0.26 | ||
| Basic earnings per common share attributable to |
$ | - | $ | 0.02 | ||
| Diluted earnings (loss) per common share attributable to |
$ | - | $ | 0.02 | ||
| Basic income per common share attributable to |
$ | 0.02 | $ | 0.28 | ||
| Diluted income per common share attributable to |
$ | 0.02 | $ | 0.28 | ||
| Weighted-average common shares outstanding– basic | 23,450 | 23,817 | ||||
| Weighted-average common shares outstanding – diluted | 23,552 | 24,013 | ||||
| Condensed Consolidated Balance Sheets | ||||||
| (unaudited) | ||||||
| (In thousands, except share and per share data) | ||||||
| 2025 | 2024 | |||||
| Assets: | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 17,942 | $ | 18,221 | ||
| Accounts receivable, net | 38,219 | 24,766 | ||||
| Prepaid expenses and other current assets | 2,901 | 3,009 | ||||
| Total current assets | 59,062 | 45,996 | ||||
| Property and equipment, net | 2,910 | 2,015 | ||||
| Operating lease right-of-use assets | 537 | 630 | ||||
| 856 | 856 | |||||
| Intangible assets, net | 808 | 841 | ||||
| Deferred income taxes | 4,157 | 4,259 | ||||
| Other assets | 1,834 | 1,834 | ||||
| Total assets | $ | 70,164 | $ | 56,431 | ||
| Liabilities and equity | ||||||
| Current liabilities: | ||||||
| Accounts payable | $ | 13,790 | $ | 8,767 | ||
| Accrued expenses and other current liabilities | 5,865 | 3,533 | ||||
| Customer incentives and deposits | 2,655 | 892 | ||||
| Lines of credit and short-term loans | 20,373 | 16,082 | ||||
| Current portion of long-term debt | 500 | 500 | ||||
| Current portion of operating lease liabilities | 219 | 276 | ||||
| Total current liabilities | 43,402 | 30,050 | ||||
| Operating lease liabilities, net of current portion | 318 | 353 | ||||
| Long-term debt | 1,738 | 1,722 | ||||
| Total liabilities | 45,458 | 32,125 | ||||
| Commitments and contingencies | ||||||
| Stockholders' equity: | ||||||
| Common stock, authorized as of 23,449,701 shares issued and outstanding as of and |
234 | 234 | ||||
| (2,075 | ) | (2,075 | ) | |||
| Additional paid-in capital | 19,913 | 19,886 | ||||
| Accumulated other comprehensive loss | (1,287 | ) | (1,198 | ) | ||
| Retained earnings | 7,921 | 7,459 | ||||
| Total stockholders' equity attributable to |
24,706 | 24,306 | ||||
| Total liabilities and stockholders’ equity | $ | 70,164 | $ | 56,431 | ||
| Condensed Consolidated Statements of Cash Flows | ||||||
| (unaudited) | ||||||
| (In thousands) | ||||||
| Three Months Ended | ||||||
| 2025 | 2024 | |||||
| Cash flows from operating activities: | ||||||
| Net income | $ | 462 | $ | 7,181 | ||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities | ||||||
| Depreciation and amortization | 382 | 475 | ||||
| Amortization of operating lease assets | 92 | 176 | ||||
| Provision for expected credit losses | - | 61 | ||||
| Deferred income tax expense | 102 | 1,088 | ||||
| Share-based compensation expense | 27 | 128 | ||||
| Gain on sale of business | - | (7,157 | ) | |||
| Changes in operating assets and liabilities, net of business disposals: | ||||||
| Accounts receivable | (11,929 | ) | (6,288 | ) | ||
| Prepaid expenses and other assets | 108 | (283 | ) | |||
| Accounts payable | 5,071 | 2,105 | ||||
| Operating lease liabilities | (185 | ) | (176 | ) | ||
| Accrued expenses, other current liabilities and customer incentives and deposits | 1,826 | 4,610 | ||||
| Net cash (used in) provided by operating activities of continuing operations | (4,044 | ) | 1,920 | |||
| Net cash used in operating activities of discontinued operations | - | (1,305 | ) | |||
| Net cash (used in) provided by operating activities | (4,044 | ) | 615 | |||
| Cash flows from investing activities: | ||||||
| Cash transferred in sale of business | - | (446 | ) | |||
| Purchases of property and equipment and capitalized software | (525 | ) | (431 | ) | ||
| Net cash used in investing activities of continuing operations | (525 | ) | (877 | ) | ||
| Net cash used in investing activities of discontinued operations | - | (1 | ) | |||
| Net cash used in investing activities | (525 | ) | (878 | ) | ||
| Cash flows from financing activities: | ||||||
| Borrowings under line of credit | 31,553 | 25,780 | ||||
| Repayments under lines of credit | (27,263 | ) | (23,657 | ) | ||
| Payments on term debt | - | (1,503 | ) | |||
| Payments of notes to seller | - | (1,120 | ) | |||
| Net cash provided by financing activities of continuing operations | 4,290 | (500 | ) | |||
| Net cash used in financing activities of discontinued operations | - | 6,844 | ||||
| Net cash provided by financing activities | 4,290 | 6,344 | ||||
| Effect of foreign exchange rate changes on cash | - | (171 | ) | |||
| Net increase (decrease) in cash and cash equivalents | (279 | ) | 5,910 | |||
| Cash and cash equivalents at beginning of year | 18,221 | 10,719 | ||||
| Cash and cash equivalents at end of year | 17,942 | 16,629 | ||||
| Less cash and cash equivalents of discontinued operations | - | 11,203 | ||||
| Cash and cash equivalents of continuing operations | $ | 17,942 | $ | 5,426 | ||
Reconciliation of GAAP to Non-GAAP Financial Measures
Non-GAAP net income attributable to
| Net income attributable to |
||||||
| Adjusted Net income attributable to |
||||||
| Diluted income per common share attributable to |
||||||
| Adjusted Diluted income per common share attributable to |
||||||
| (In thousands) | ||||||
| Three Months Ended | ||||||
| 2025 | 2024 | |||||
| Net Income attributable to |
$ | 462 | $ | 6,627 | ||
| Adjustments to Consolidated EBITDA (net of taxes)* | 73 | (5,292 | ) | |||
| Adjusted Net income attributable to |
$ | 535 | $ | 1,335 | ||
| Diluted income per common share attributable to |
$ | 0.02 | $ | 0.28 | ||
| Adjustments to Consolidated EBITDA per share (net of taxes) | - | (0.22 | ) | |||
| Adjusted Diluted income per common share attributable to |
$ | 0.02 | $ | 0.06 | ||
| * 2025 Adjustments to Consolidated EBITDA include |
||||||
| Net Income to Consolidated Adjusted EBITDA to Adjusted EBITDA attributable to Reconciliation |
|||||||
| (In thousands) | |||||||
| Three Months Ended | |||||||
| 2025 | 2024 | ||||||
| Consolidated net income from continuing operations | $ | 462 | $ | 6,796 | |||
| Depreciation and amortization from continuing operations | 367 | 475 | |||||
| Interest expense from continuing operations | 469 | 475 | |||||
| Income tax expense from continuing operations | 114 | 1,393 | |||||
| Other expense (income) from continuing operations | (9 | ) | 7 | ||||
| EBITDA of Discontinued Operations | - | 937 | |||||
| Consolidated EBITDA | 1,403 | 10,083 | |||||
| Review of Strategic Alternatives | 66 | 330 | |||||
| Gain on Sale of Business | - | (7,157 | ) | ||||
| Share Based Compensation | 27 | 128 | |||||
| Consolidated Adjusted EBITDA | 1,496 | 3,384 | |||||
| Adjusted EBITDA attributable to non controlling interest | - | (918 | ) | ||||
| Adjusted EBITDA attributable to |
$ | 1,496 | $ | 2,466 | |||
Source:
Source: SPAR Group, Inc.
